Showing results (391-400 of 588) with videos related to

Sort By:
Pageof 59
Internal Medicine Journal|February 21, 2008
Guidelines for the prevention of sepsis in asplenic and hyposplenic patientsD Spelman, J Buttery, A Daley, et al.
The Prostate|April 26, 2006
Germline ATBF1 mutations and prostate cancer riskJunyan Xu, Jurga Sauvageot, Charles M Ewing, et al.
Frontiers in Immunology|July 24, 2019
IL-6 Mediated Transcriptional Programming of Naïve CD4+ T Cells in Early Rheumatoid Arthritis Drives Dysregulated Effector FunctionLaura A Ridgley, Amy E Anderson, Nicola J Maney, et al.
BMJ Open|April 16, 2024
Operational complexities in international clinical trials: a systematic review of challenges and proposed solutionsLeher Gumber, Opeyemi Agbeleye, Alex Inskip, et al.
The Prostate|May 27, 1999
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancerE P Wilkens, D Freije, J Xu, et al.
Clinical and Experimental Immunology|November 21, 1997
Humanized anti-CD4 monoclonal antibody therapy of autoimmune and inflammatory diseaseJ D Isaacs, N Burrows, M Wing, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 26, 2015
Clinical utility of random anti-tumor necrosis factor drug-level testing and measurement of antidrug antibodies on the long-term treatment response in rheumatoid arthritisMeghna Jani, Hector Chinoy, Richard B Warren, et al.
Diabetes Care|September 10, 1999
Immunogenetic analysis suggests different pathogenesis for obese and lean African-Americans with diabetic ketoacidosisG E Umpierrez, W Woo, W A Hagopian, et al.
Arthritis and Rheumatism|October 19, 2000
Fcgamma receptor type IIIA is associated with rheumatoid arthritis in two distinct ethnic groupsA W Morgan, B Griffiths, F Ponchel, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 28, 2016
Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid ArthritisDarren Plant, Amy Webster, Nisha Nair, et al.
Pageof 59